Metropolitan Life Insurance CO Sage Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

  • $2.27 Billion
  • Q1 2024

A detailed history of Metropolitan Life Insurance CO transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Metropolitan Life Insurance CO holds 3,029 shares of SAGE stock, worth $32,167. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,029
Previous 3,029 -0.0%
Holding current value
$32,167
Previous $65,000 13.85%
% of portfolio
0.0%
Previous 0.0%

Shares

52 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$16.75 - $48.98 $2,311 - $6,759
138 Added 4.77%
3,029 $62,000
Q1 2023

May 15, 2023
SELL
$37.27 - $46.57 $9,578 - $11,968
-257 Reduced 8.16%
2,891 $121,000
Q4 2022

Jun 14, 2023
BUY
$32.2 - $43.61 $8,275 - $11,207
257 Added 8.89%
3,148 $120 Million
Q3 2022

Jun 14, 2023
BUY
$32.28 - $43.27 $8,295 - $11,120
257 Added 8.89%
3,148 $123 Million
Q2 2022

Jun 20, 2023
BUY
$27.52 - $37.99 $7,072 - $9,763
257 Added 8.89%
3,148 $101,000
Q2 2022

Mar 30, 2023
BUY
$27.52 - $37.99 $58,452 - $80,690
2,124 Added 207.42%
3,148 $101,000
Q2 2022

Aug 11, 2022
BUY
$27.52 - $37.99 $86,632 - $119,592
3,148 New
3,148 $102,000
Q1 2022

May 12, 2022
SELL
$30.71 - $45.71 $31,447 - $46,807
-1,024 Closed
0 $0
Q4 2021

Jun 21, 2023
SELL
$37.06 - $47.11 $69,191 - $87,954
-1,867 Reduced 64.58%
1,024 $43,000
Q4 2021

Mar 30, 2023
SELL
$37.06 - $47.11 $1,408 - $1,790
-38 Reduced 3.58%
1,024 $43,000
Q4 2021

Feb 15, 2022
BUY
$37.06 - $47.11 $37,949 - $48,240
1,024 New
1,024 $44,000
Q3 2021

Jun 21, 2023
SELL
$40.26 - $57.37 $75,286 - $107,281
-1,870 Reduced 64.68%
1,021 $45.2 Million
Q3 2021

Nov 15, 2021
SELL
$40.26 - $57.37 $42,756 - $60,926
-1,062 Closed
0 $0
Q2 2021

Jun 21, 2023
SELL
$54.88 - $79.29 $100,375 - $145,021
-1,829 Reduced 63.27%
1,062 $60,000
Q2 2021

Mar 30, 2023
BUY
$54.88 - $79.29 $43,190 - $62,401
787 Added 286.18%
1,062 $60,000
Q2 2021

Aug 16, 2021
BUY
$54.88 - $79.29 $58,282 - $84,205
1,062 New
1,062 $60,000
Q1 2021

Jun 26, 2023
SELL
$70.65 - $96.76 $117,067 - $160,331
-1,657 Reduced 57.32%
1,234 $92.4 Million
Q1 2021

Mar 30, 2023
SELL
$70.65 - $96.76 $65,987 - $90,373
-934 Reduced 77.25%
275 $20,000
Q1 2021

May 14, 2021
SELL
$70.65 - $96.76 $85,415 - $116,982
-1,209 Closed
0 $21,000
Q4 2020

Jun 22, 2023
SELL
$58.41 - $89.06 $98,245 - $149,798
-1,682 Reduced 58.18%
1,209 $104,000
Q4 2020

Mar 30, 2023
SELL
$58.41 - $89.06 $2,044 - $3,117
-35 Reduced 2.81%
1,209 $104,000
Q4 2020

Feb 16, 2021
SELL
$58.41 - $89.06 $2,044 - $3,117
-35 Reduced 2.81%
1,209 $105,000
Q3 2020

Jun 26, 2023
SELL
$41.13 - $62.45 $67,741 - $102,855
-1,647 Reduced 56.97%
1,244 $76,000
Q3 2020

Mar 30, 2023
SELL
$41.13 - $62.45 $822 - $1,249
-20 Reduced 1.58%
1,244 $76,000
Q3 2020

Nov 13, 2020
SELL
$41.13 - $62.45 $822 - $1,249
-20 Reduced 1.58%
1,244 $76,000
Q2 2020

Jun 26, 2023
SELL
$25.95 - $43.15 $42,220 - $70,205
-1,627 Reduced 56.28%
1,264 $52,000
Q2 2020

Mar 30, 2023
SELL
$25.95 - $43.15 $60,152 - $100,021
-2,318 Reduced 64.71%
1,264 $52,000
Q2 2020

Aug 14, 2020
SELL
$25.95 - $43.15 $60,152 - $100,021
-2,318 Reduced 64.71%
1,264 $53,000
Q1 2020

Jul 12, 2023
BUY
$26.15 - $77.24 $18,069 - $53,372
691 Added 23.9%
3,582 $102,000
Q1 2020

Mar 30, 2023
SELL
$26.15 - $77.24 $2,954 - $8,728
-113 Reduced 3.06%
3,582 $102,000
Q1 2020

May 15, 2020
SELL
$26.15 - $77.24 $2,954 - $8,728
-113 Reduced 3.06%
3,582 $103,000
Q4 2019

Jul 12, 2023
BUY
$60.18 - $154.77 $48,384 - $124,435
804 Added 27.81%
3,695 $266,000
Q4 2019

Mar 30, 2023
SELL
$60.18 - $154.77 $1,203 - $3,095
-20 Reduced 0.54%
3,695 $266,000
Q4 2019

Feb 14, 2020
SELL
$60.18 - $154.77 $1,203 - $3,095
-20 Reduced 0.54%
3,695 $267,000
Q3 2019

Jul 12, 2023
BUY
$140.29 - $189.96 $115,598 - $156,527
824 Added 28.5%
3,715 $521,000
Q3 2019

Mar 30, 2023
BUY
$140.29 - $189.96 $17,957 - $24,314
128 Added 3.57%
3,715 $521,000
Q3 2019

Nov 14, 2019
BUY
$140.29 - $189.96 $17,957 - $24,314
128 Added 3.57%
3,715 $521,000
Q2 2019

Jul 12, 2023
BUY
$157.85 - $183.09 $109,863 - $127,430
696 Added 24.07%
3,587 $656,000
Q2 2019

Mar 30, 2023
SELL
$157.85 - $183.09 $13,101 - $15,196
-83 Reduced 2.26%
3,587 $656,000
Q2 2019

Aug 14, 2019
SELL
$157.85 - $183.09 $13,101 - $15,196
-83 Reduced 2.26%
3,587 $657,000
Q1 2019

Jul 13, 2023
BUY
$89.33 - $163.65 $69,588 - $127,483
779 Added 26.95%
3,670 $583,000
Q1 2019

Mar 30, 2023
BUY
$89.33 - $163.65 $46,630 - $85,425
522 Added 16.58%
3,670 $583,000
Q1 2019

May 16, 2019
BUY
$89.33 - $163.65 $197,687 - $362,157
2,213 Added 151.89%
3,670 $583,000
Q1 2019

May 15, 2019
SELL
$89.33 - $163.65 $182,143 - $333,682
-2,039 Reduced 58.32%
1,457 $64,000
Q4 2018

Jul 13, 2023
BUY
$81.94 - $139.71 $49,573 - $84,524
605 Added 20.93%
3,496 $334,000
Q4 2018

Feb 14, 2019
SELL
$81.94 - $139.71 $983 - $1,676
-12 Reduced 0.34%
3,496 $335,000
Q3 2018

Jul 13, 2023
BUY
$138.11 - $169.04 $85,213 - $104,297
617 Added 21.34%
3,508 $496 Million
Q3 2018

Nov 14, 2018
SELL
$138.11 - $169.04 $9,529 - $11,663
-69 Reduced 1.93%
3,508 $496,000
Q2 2018

Aug 15, 2018
SELL
$140.36 - $175.76 $1.33 Million - $1.67 Million
-9,489 Reduced 72.62%
3,577 $0
Q1 2018

May 15, 2018
BUY
$152.15 - $192.33 $199,925 - $252,721
1,314 Added 11.18%
13,066 $0
Q4 2017

Feb 15, 2018
SELL
$60.72 - $167.34 $710,424 - $1.96 Million
-11,700 Reduced 49.89%
11,752 $1.94 Million
Q2 2017

Aug 14, 2017
BUY
N/A
23,452
23,452 $1.87 Million

Others Institutions Holding SAGE

# of Institutions
222
Shares Held
52.7M
Call Options Held
207K
Put Options Held
191K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $631M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email